ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Case Report: Abscess as a Manifestation of Autoinflammatory Disease

Katherine Chakrabarti, MD, & Andrew Vreede, MD  |  June 14, 2022

Abscesses are typically caused by infections, but some are, instead, sterile. Aseptic abscesses (AAs) are characterized by the same neutrophil-rich histo­pathology as infectious abscesses; however, they don’t improve with antibiotics. Rather, AAs require treatment with anti-inflammatory medications. Although relatively rare, this phenomenon is important for rheumatologists to recognize given its frequent association with under­lying systemic…

Filed under:Conditions Tagged with:abscessaseptic abscesscase reportSAPHO

Concierge Care: Basketball, Hotels & the Future of Rheumatology

Philip Seo, MD, MHS  |  June 14, 2022

I wouldn’t normally look to professional basketball as a model for healthcare, but sometimes answers come from unexpected places. The observation that elite athletes are not like you and me—medically speaking—is not new. In the second century AD, the pontifex maximus in Pergamum recognized this fact and appointed Claudius Galen physician to the gladiators, making…

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out RheumWorkforce Tagged with:burnoutconcierge medicine

ACR Delegation Asks AMA to Address Issues Impacting Rheumatology

From the College  |  June 3, 2022

After two years of special virtual sessions, the AMA House of Delegates will reconvene in person June 10–15. ACR representatives will focus on Medicare physician payment system reform, national drug shortages, funding the new Advanced Research Projects Agency for Health and more.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Advanced Research Projects Agency for Health (ARPA-H)AMA House of Delegates (HOD)Drug shortage

In 2022, Advocacy 101 Returns to Washington, D.C.

Mary Beth Nierengarten  |  June 3, 2022

ACR and ARP members converged on Capitol Hill in May to urge lawmakers to support legislation related to workforce expansion and patient access to care following training sessions presented by ACR staff dedicated to legislative affairs.

Filed under:Education & TrainingLegislation & Advocacy Tagged with:Advocacy 101Legislation & Advocacy

Conservation of Drugs: The Impact of Acute Immunomodulator Prescribing for COVID-19 on Rheumatology Patients

Sara Jo Santangelo, PharmD candidate, & Wendy Ramey, BSPharm, RPh, CSP  |  May 23, 2022

In its COVID-19 treatment guidelines, the National Institutes of Health (NIH) lists several drugs commonly prescribed for patients with rheumatic conditions as potential therapies in those who are hospitalized for COVID-19 and require high-flow oxygen, noninvasive ventilation, intermittent ventilation (IMV) or extracorporeal membrane oxygenation (ECMO), as of Aug. 25, 2021, and current as this is…

Filed under:Drug UpdatesInterprofessional Perspective Tagged with:baricitinibCOVID-19immunomodulatory agentInterprofessional PerspectivesarilumabtocilizumabTofacitinib

Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

Lara C. Pullen, PhD  |  May 20, 2022

HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

Filed under:Axial SpondyloarthritisConditionsPsoriatic ArthritisResearch Rheum Tagged with:Arthritis Care & ResearchAxial Psoriatic Arthritis (axPsA)axial spondyloarthritis (SpA)HLA-B27phenotypepsoriatic arthritis

Overcome Fear & Misinformation: Solutions for Women with Inflammatory Arthritis Considering Pregnancy

Lara C. Pullen, PhD  |  May 20, 2022

Many women with inflammatory arthritis stop filling prescriptions for medications to treat their disease during pregnancy, putting themselves at risk of disability and joint damage. Birru Talabi et al. examined why, finding that some women discontinue their medications out of fear, while others receive conflicting advice from providers or misinformation about medication safety.

Filed under:Conditions Tagged with:ACR Open Rheumatologybreastfeedingmisinformationpregnancypregnant womenreproductive healthWomen

Golden light on the US Capitol with a blooming cherry tree in the foreground.

The ACR Returns to In-Person Hill Day to Protect Patient Access to Care

From the College  |  May 19, 2022

More than 70 rheumatologists and rheumatology health professionals convened in Washington, D.C., to advocate on behalf of legislation that would reduce patients’ out-of-pocket drug costs and help grow America’s healthcare workforce.

Filed under:American College of RheumatologyCareer DevelopmentLegislation & Advocacy Tagged with:Advocacy Leadership ConferenceCapitol Hill fly-indrug costsworkforce shortage

Washington Rheumatology Alliance in the Spotlight

Linda Childers  |  May 19, 2022

The Washington Rheumatology Alliance is focused on creative ways to increase the rheumatology workforce to meet the demand for care, such as instituting clinical rotations in rheumatology for nurse practitioner programs and advocating for pediatric rheumatologist loan forgiveness.

Filed under:Professional TopicsProfilesWorkforce Tagged with:Jeff PetersonMelissa FesselPediatric Subspecialty Loan ForgivenessState and local updateWashington Rheumatology Alliance

Scleroderma & the Gut: New Frontiers in Diagnosis & Tips on Management

Samantha C. Shapiro, MD  |  May 12, 2022

McMahan et al. examined how abnormal gastrointestinal (GI) transit may contribute to GI severity and symptoms in patients with systemic sclerosis (SSc). About 90% of people with SSc have GI tract involvement, and understanding the connection between GI symptoms, their severity and abnormal GI transit may permit targeted therapeutic approaches for these patients.

Filed under:ConditionsResearch RheumSystemic Sclerosis Tagged with:Arthritis Care & Researchgutrefractory gastroesophageal reflux disease (GERD)Sclerodermasystemic sclerosis (SSc)

  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 337
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences